Achieve Life Sciences (ACHV) Equity Ratio (2010 - 2026)

Achieve Life Sciences has disclosed Equity Ratio across 17 years of filings, most recently posting 0.32 for Q1 2026.

• Quarterly Equity Ratio fell 14.15% year-over-year to 0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.32 (down 14.15% YoY) and the FY2025 annual result came in at 0.51, down 4.82% from the prior year.
• Equity Ratio retreated to 0.32 in Q1 2026, from 0.51 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.71 in Q2 2025 and troughed at 0.07 in Q4 2023.
• A 5-year average of 0.4 and a median of 0.39 in 2022 frame the typical range for Equity Ratio.
• Annual changes were most pronounced in 2023 — Equity Ratio slumped 126.98% — and 2024, when it surged 3215.58%.
• Tracing ACHV's Equity Ratio over 5 years: stood at 0.28 in 2022, then sank by 126.98% to 0.07 in 2023, then jumped by 823.69% to 0.54 in 2024, then declined by 4.82% to 0.51 in 2025, then slumped by 37.36% to 0.32 in 2026.
• Business Quant data shows ACHV's Equity Ratio at 0.32 in Q1 2026, 0.51 in Q4 2025, and 0.65 in Q3 2025.